Lodestone Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.86M Sell
13,415
-34
-0.3% -$11.6K 1.72% 9
2026
Q1
$4.73M Buy
13,449
+56
+0.4% +$20K 1.88% 8
2025
Q4
$4.38M Sell
13,393
-227
-2% -$72K 1.79% 10
2025
Q3
$3.84M Buy
13,620
+316
+2% +$91.6K 1.73% 12
2025
Q2
$3.71M Buy
13,304
+103
+0.8% +$29.2K 1.81% 12
2025
Q1
$4.11M Sell
13,201
-1,052
-7% -$311K 2.19% 10
2024
Q4
$3.71M Sell
14,253
-380
-3% -$113K 1.86% 12
2024
Q3
$4.71M Buy
14,633
+361
+3% +$118K 2.36% 6
2024
Q2
$4.46M Buy
14,272
+43
+0.3% +$12.6K 2.35% 4
2024
Q1
$4.05M Buy
14,229
+11
+0.1% +$3.22K 2.12% 7
2023
Q4
$4.1M Sell
14,218
-729
-5% -$199K 2.37% 5
2023
Q3
$4.02M Sell
14,947
-259
-2% -$64.6K 2.81% 5
2023
Q2
$3.38M Buy
15,206
+1,767
+13% +$410K 2.31% 7
2023
Q1
$3.25M Sell
13,439
-233
-2% -$57.2K 2.5% 6
2022
Q4
$3.59M Buy
+13,672
New +$3.66M 2.9% 4

Other funds holding AMGN

Lodestone Wealth Management's AMGN Position: Q2 2026 in Review

Lodestone Wealth Management reduced its Amgen (AMGN) stake by 0.25% in Q2 2026, selling an estimated $11.6K and leaving 13,415 shares worth $4.86M. The position accounts for 1.72% of the portfolio, ranked #9.

Lodestone Wealth Management first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. 1,278 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Lodestone Wealth Management held 13,415 shares of Amgen worth $4.86M as of Q2 2026.
  • Lodestone Wealth Management sold 34 Amgen shares in Q2 2026, an estimated $11.6K.
  • Amgen made up 1.72% of Lodestone Wealth Management's portfolio in Q2 2026, its #9 holding.
  • Lodestone Wealth Management first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • 1,278 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Lodestone Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.